ToxSci Advance Access originally published online on July 25, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Toxicological Sciences 75, 458-467 (2003)
Copyright © 2003 by the Society of Toxicology
SYSTEMS TOXICOLOGY |
Effect of N-Acetylcysteine on Acetaminophen Toxicity in Mice: Relationship to Reactive Nitrogen and Cytokine Formation
,1


* Departments of Pediatrics,
Pharmacology, and
Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72202
The relationship between acetaminophen (APAP) reactive metabolite formation, nitrotyrosine (NT) production, and cytokine elevation in APAP toxicity was investigated. Mice were dosed with 300 mg/kg of APAP and sacrificed at 1, 2, 4, 8, and 12 h. Serum aspartate aminotransferase (AST) was elevated by 4 h. The relative amount of NT correlated with toxicity and was localized in the necrotic cells. IL-1b was increased at 1 h, whereas IL-6, MIP-2, and MCP-1 were increased by 48 h. To determine the importance of reversible versus toxic events, N-acetylcysteine (NAC) was administered to mice either before APAP or 1, 2, or 4 h after APAP. The animals were sacrificed at 12 h. NAC treatment before APAP resulted in serum AST, serum nitrate plus nitrite as a measure of nitric oxide (NO) production, and hepatic cytokine levels that were similar to the controls. No APAP protein adducts or NT was present in these animals. In mice treated with NAC at 1 h, cytokines and serum AST were normal at 12 h, but APAP protein adducts were present in the hepatic centrilobular areas. No NT was present in these animals. In mice treated with NAC at 2 h and sacrificed at 12 h, serum AST was reduced by 80%. APAP adducts and NT were present in the centrilobular areas. Mice receiving NAC at 4 h had no protection from toxicity and serum nitrate plus nitrite. The NT and cytokine levels were similar to those of mice receiving APAP alone. The data suggest a relationship between metabolic events in APAP toxicity and the upregulation of NO, and IL-1b. IL-6, MIP-2, and MCP-1 appear to follow the toxicity. While it is a pre-requisite event, covalent binding per se does not appear to be a toxic event in the development of toxicity.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Yalcin, A Bilgili, I Onbasilar, G Eraslan, and M Ozdemir Synergistic action of sodium selenite and N-acetylcysteine in acetaminophen-induced liver damage Human and Experimental Toxicology, May 1, 2008; 27(5): 425 - 429. [Abstract] [PDF] |
||||
![]() |
L. A. McConnachie, I. Mohar, F. N. Hudson, C. B. Ware, W. C. Ladiges, C. Fernandez, S. Chatterton-Kirchmeier, C. C. White, R. H. Pierce, and T. J. Kavanagh Glutamate Cysteine Ligase Modifier Subunit Deficiency and Gender as Determinants of Acetaminophen-Induced Hepatotoxicity in Mice Toxicol. Sci., October 1, 2007; 99(2): 628 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C Henderson, K. J Pollock, J. Frew, A. C Mackinnon, R. A Flavell, R. J Davis, T. Sethi, and K. J Simpson Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure Gut, July 1, 2007; 56(7): 982 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Terneus, K. K. Kiningham, A. B. Carpenter, S. B. Sullivan, and M. A. Valentovic Comparison of S-Adenosyl-L-methionine and N-Acetylcysteine Protective Effects on Acetaminophen Hepatic Toxicity J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 99 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Botta, S. Shi, C. C. White, M. J. Dabrowski, C. L. Keener, S. L. Srinouanprachanh, F. M. Farin, C. B. Ware, W. C. Ladiges, R. H. Pierce, et al. Acetaminophen-induced Liver Injury Is Attenuated in Male Glutamate-cysteine Ligase Transgenic Mice J. Biol. Chem., September 29, 2006; 281(39): 28865 - 28875. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Powell, O. Kosyk, P. K. Ross, R. Schoonhoven, G. Boysen, J. A. Swenberg, A. N. Heinloth, G. A. Boorman, M. L. Cunningham, R. S. Paules, et al. Phenotypic Anchoring of Acetaminophen-Induced Oxidative Stress with Gene Expression Profiles in Rat Liver Toxicol. Sci., September 1, 2006; 93(1): 213 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. James, E. M. Alonso, L. S. Hynan, J. A. Hinson, T. J. Davern, W. M. Lee, R. H. Squires, and the Pediatric Acute Liver Failure Study Group Detection of Acetaminophen Protein Adducts in Children With Acute Liver Failure of Indeterminate Cause Pediatrics, September 1, 2006; 118(3): e676 - e681. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Donahower, S. S. McCullough, R. Kurten, L. W. Lamps, P. Simpson, J. A. Hinson, and L. P. James Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity Am J Physiol Gastrointest Liver Physiol, July 1, 2006; 291(1): G102 - G109. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jaeschke and M. L. Bajt Intracellular Signaling Mechanisms of Acetaminophen-Induced Liver Cell Death Toxicol. Sci., January 1, 2006; 89(1): 31 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cover, A. Mansouri, T. R. Knight, M. L. Bajt, J. J. Lemasters, D. Pessayre, and H. Jaeschke Peroxynitrite-Induced Mitochondrial and Endonuclease-Mediated Nuclear DNA Damage in Acetaminophen Hepatotoxicity J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 879 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. James, P. M. Simpson, H. C. Farrar, G. L. Kearns, G. S. Wasserman, J. L. Blumer, M. D. Reed, J. E. Sullivan, J. A. Hinson, and The Pediatric Pharmacology Research Unit Network Cytokines and Toxicity in Acetaminophen Overdose J. Clin. Pharmacol., October 1, 2005; 45(10): 1165 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Reid, R. C. Kurten, S. S. McCullough, R. W. Brock, and J. A. Hinson Mechanisms of Acetaminophen-Induced Hepatotoxicity: Role of Oxidative Stress and Mitochondrial Permeability Transition in Freshly Isolated Mouse Hepatocytes J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 509 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. James, P. R. Mayeux, and J. A. Hinson ACETAMINOPHEN-INDUCED HEPATOTOXICITY Drug Metab. Dispos., December 1, 2003; 31(12): 1499 - 1506. [Abstract] [Full Text] [PDF] |
||||








